NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES Silex Microsystems AB (“Silex” or the “Company”), the leading pure-play MEMS foundry globally[1], announces…
We are pleased to announce that Maria Engström has been appointed Chief Financial Officer. Maria Engström brings over 25 years of experience across senior business and finance functions and most recently serving as CFO of Cinclus Pharma and previously at Sedana Medical. She has held a range of financial roles within technology- and research-intensive companies,…
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES The Board of Silex Microsystems AB (“Silex” or “the Company”) has decided to explore…
Silex Microsystems (”Silex”), the leading pure-play MEMS foundry globally, announces today that the ownership change, announced on June 13, 2025, has received the necessary regulatory approvals and is now completed. With this change, Silex is re-established as a Swedish majority owned company, with a consortium led by Bure Equity (“Bure”) and Creades, including Grenspecialisten, 3S…
Silex Microsystems (”Silex”), the leading pure-play MEMS foundry globally, announces that a Swedish consortium, led by Bure Equity (“Bure”) and Creades, including Grenspecialisten, 3S Invest, SEB-Stiftelsen and TomEnterprise (together the “Consortium”), has acquired shares in the company from the current main owner Sai Microelectronics (the “Transaction”), and will together with members of the management team…